Clinical Trials Browser

Phase 2 × Carcinoma, Ovarian Epithelial × Imatinib Mesylate × Clear all

NCT00039585 2015-04-30

Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential Tumor

Phase 2 Completed

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00510653 2013-08-23

Gleevec Study for Patients With Ovarian Cancer

Phase 2 Completed

73 enrolled 4 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00041041 2013-02-20

Imatinib Mesylate in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer

Phase 2 Completed

Carcinoma, Ovarian Epithelial